Schedule Appointment:
India:-10:00am-7:00pm
Bangladesh:-10:30am-7:30 pm

Schedule Appointment:

India:-10:00 am-7:00 pm

Bangladesh:-10:30 am-7:30 pm

 

Stemcelline Vial - UC Xeno - Free Mesenchymal cells

Introduction

100 million in 5ml

The majority of MSC applications include the therapy of immune- and inflammation-mediated disorders as well as tissue degradation, with MSCs showing significant promise for the treatment of incurable diseases.

Fetal bovine serum (FBS), a popular supplement for cell growth but also a potential risk for transmission of infections obtained from animals, is a component of conventional MSC cultures.

How are we different?
  • The health and medicine use of the donor is just two factors that affect the quality of MSCs. 
  • The quantity of MSCs recovered from older individuals is often modest since in vivo MSC synthesis declines with age. Therefore, creating a technique that consistently provides high MSCs is crucial for cell therapy.

The possibility of safe usage in human clinical therapy was demonstrated using xeno-free media. A xeno-free medium must be studied before being used for MSC cultures since these xeno-free media have various effects on MSCs.

To find a common cultural setting for all of these MSC sources, we experimented with a commercial xeno-free. The cells’ population doubling times (P2 to P6) and the expression of surface markers were examined.

We found two medium candidates that supported the isolation and culture of UC-MSCs using UC as the main screening. MSCs produced from BM and AD can also grow in these environments. The cells might develop into chondrocyte, adipocyte, and osteoblast/osteocyte lineages.

In order to determine the safety and viability of using UC-MSCs to treat bronchopulmonary dysplasia and chronic obstructive pulmonary disease, we are now undertaking a phase 1 clinical investigation.